Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesothelioma.

Epithelial-to-mesenchymal transition (EMT) is the fundamental process by which an epithelial cell loses its epithelial characteristics including cell polarity and acquires mesenchymal and stemness-related features. Therefore, we investigated whether malignant pleural mesothelioma (MPMs) histologies were associated with specific patterns of expression of a selected set of genes related to EMT, cell polarity and stemness features. The association between MPM histologies and genes expression were explored using active and passive Principal Components Analysis-based biplots and PAM analysis that provided evidence that with respect to normal tissues, MPMs histologies were better characterized by specific patterns of expression of genes involved in EMT activation, cell polarity and stemness.

[1]  F. Portillo,et al.  Transcriptional regulation of cell polarity in EMT and cancer , 2008, Oncogene.

[2]  E. Sabo,et al.  Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study , 2005, Modern Pathology.

[3]  A. Le Bivic,et al.  Polarity complex proteins. , 2008, Biochimica et biophysica acta.

[4]  Goberdhan P Dimri,et al.  BMI1 Cooperates with H-RAS to Induce an Aggressive Breast Cancer Phenotype with Brain Metastases , 2009, Oncogene.

[5]  A. Mazumdar,et al.  How one becomes many: Blastoderm cellularization in Drosophila melanogaster , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[6]  J. Lehmann,et al.  MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  I. Petersen,et al.  Expression of the Cell Adhesion Molecule CD146/MCAM in Non-Small Cell Lung Cancer , 2003, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[8]  M. Kwon,et al.  p21 as a prognostic factor in non-small cell lung carcinomas. , 2006, Pathology, research and practice.

[9]  P. Fortina,et al.  p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo , 2009, Proceedings of the National Academy of Sciences.

[10]  K Satyamoorthy,et al.  N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. , 2001, Cancer research.

[11]  H. Richardson,et al.  scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila , 2003, The EMBO journal.

[12]  D. Tuveson,et al.  Twist induces an epithelial-mesenchymal transition to facilitate tumor metastasis , 2004, Cancer biology & therapy.

[13]  Riccardo Fodde,et al.  Wnt/β-catenin signaling in cancer stemness and malignant behavior , 2007 .

[14]  Shuji Ogino,et al.  p21 Expression in Colon Cancer and Modifying Effects of Patient Age and Body Mass Index on Prognosis , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[15]  M. Ozawa,et al.  The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation , 2004, Journal of Cell Science.

[16]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[17]  Feng Jiang,et al.  Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer , 2009, Molecular Cancer Research.

[18]  Mariann Bienz,et al.  β-Catenin: A Pivot between Cell Adhesion and Wnt Signalling , 2005, Current Biology.

[19]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[20]  D. Amadori,et al.  Isolation of stem/progenitor cells from normal lung tissue of adult humans , 2009, Cell proliferation.

[21]  K. Nakayama,et al.  Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes. , 2010, Gynecologic oncology.

[22]  S. Russell,et al.  The Scribble and Par complexes in polarity and migration: friends or foes? , 2006, Trends in cell biology.

[23]  Victoria Bolós,et al.  Notch signaling in development and cancer. , 2007, Endocrine reviews.

[24]  J. Januschke,et al.  Drosophila asymmetric division, polarity and cancer , 2008, Oncogene.

[25]  P. Meltzer,et al.  Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility , 2006, Oncogene.

[26]  C. Porta,et al.  SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. , 2005, Cancer research.

[27]  T. Nakano,et al.  Immunocytochemistry of CD146 is useful to discriminate between malignant pleural mesothelioma and reactive mesothelium , 2010, Modern Pathology.

[28]  D. Gary Gilliland,et al.  Cancer biology: Summing up cancer stem cells , 2005, Nature.

[29]  L. Cantley,et al.  Mesenchymal-Epithelial Transition in epithelial response to injury: the role of Foxc2 , 2009, Oncogene.

[30]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  L. Murphy,et al.  Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype , 2009, Virchows Archiv.

[32]  E. Rodriguez-Boulan,et al.  The epithelial polarity program: machineries involved and their hijacking by cancer , 2008, Oncogene.

[33]  M. Kasuga,et al.  Dedifferentiation and decreased expression of adhesion molecules, E-cadherin and ZO-1, in colorectal cancer are closely related to liver metastasis. , 2003, Journal of experimental & clinical cancer research : CR.

[34]  H. An,et al.  Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma , 2010, Cancer science.

[35]  I. Shih.  The role of CD146 (Mel‐CAM) in biology and pathology , 1999, The Journal of pathology.

[36]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Bidlingmaier,et al.  Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. , 2009, Cancer research.

[38]  S. Groshen,et al.  Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[39]  P. V. van Diest,et al.  Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[40]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[41]  W. Huttner,et al.  Asymmetric cell division during neurogenesis in Drosophila and vertebrates , 2003, Mechanisms of Development.

[42]  M. Gariboldi,et al.  M‐CAM expression as marker of poor prognosis in epithelial ovarian cancer , 2006, International journal of cancer.

[43]  Zhong Chen,et al.  Suppression of ABCG2 inhibits cancer cell proliferation , 2009, International journal of cancer.

[44]  P. V. van Diest,et al.  Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. , 2008, Biochemical and biophysical research communications.

[45]  E. Bandrés,et al.  TWIST1 Overexpression is Associated with Nodal Invasion and Male Sex in Primary Colorectal Cancer , 2008, Annals of Surgical Oncology.

[46]  W. Hsu,et al.  Prognostic significance of hypoxia-inducible factor-1α, TWIST1 and Snail expression in resectable non-small cell lung cancer , 2009, Thorax.

[47]  S. Mutsaers,et al.  The Potential of Mesothelial Cells in Tissue Engineering and Regenerative Medicine Applications , 2007, The International journal of artificial organs.

[48]  J. Schalken,et al.  Cadherin switching in human prostate cancer progression. , 2000, Cancer research.

[49]  Stuart A. Aaronson,et al.  Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.

[50]  M. Amin,et al.  Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. , 2001, Gene.

[51]  D. Bilder.  Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. , 2004, Genes & development.

[52]  M. Imamura,et al.  N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma , 2004, Clinical Cancer Research.

[53]  Tsippi Iny Stein,et al.  GeneAnnot: comprehensive two-way linking between oligonucleotide array probesets and GeneCards genes. , 2004, Bioinformatics.

[54]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[55]  F. Radtke,et al.  Multiple functions of Notch signaling in self‐renewing organs and cancer , 2006, FEBS letters.

[56]  F. Bertucci,et al.  CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines , 2009, Breast Cancer Research.

[57]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[58]  David J Sugarbaker,et al.  Tumorigenesis and Neoplastic Progression Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling , 2005 .